Peripartum haemorrhage remains one of the main causes of maternal mortality world-wide. The German, Austrian and Swiss Societies of Gynaecology and Obstetrics have updated the current guidelines for the treatment of peripartum haemorrhage together with the German Society of Anaesthesiology and Intensive Care Medicine and the Society of Thrombosis and Haemostasis Research. The recommendations have been the result of a thorough review of the available scientific literature and a consensus process involving all members of the guideline group. A key element of the anaesthesiological and haemostatic management is the development of a multidisciplinary standard operating procedure combining surgical as well as medical and haemostatic treatments depending on the severity of bleeding. The guideline underscores the value of clinical and laboratory diagnostics of peripartum haemorrhage as early as possible, even pre-emptively. This allows for an early identification of causes of bleeding and a specific treatment. The guideline comprises evidence-based recommendations for the use of uterotonics, tranexamic acid and blood products such as factor concentrates, fresh frozen plasma, platelet concentrates, packed red blood cells, recombinant activated factor VII and desmopressin. In addition, recommendations for blood conservation strategies involving the use of cell salvage, permissive hypotension and transfusion triggers are given.

Keywords:
Peripartum haemorrhage, Standard operating procedures, Uterotonics, Haemostasis, Tranexamic acid, Coagulation factor concentrates, Blood conservation
1.
Weeks A: The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next? BJOG 2015;122:202-210.
2.
Hofmeyr GJ, Qureshi Z: Preventing deaths due to haemorrhage. Best Pract Res Clin Obstet Gynaecol 2016;36:68-82.
3.
Bonnar J: Massive obstetric haemorrhage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:1-18.
4.
Samangaya R, Pennington R, Vause S: Factors relating to a rising incidence of major postpartum haemorrhage. BJOG 2010;117:370-371.
5.
Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM: Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol 2015;125:5-12.
6.
Callaghan WM, Kuklina EV, Berg CJ: Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol 2010;202:353-356.
7.
Muir HA: Pharmacologic intervention for managing uterine atony and related maternal hemorrhage: what is the most effective drug dose? Can J Anaesth 2013;60:1047-1053.
8.
Dutton RP, Lee LA, Stephens LS, Posner KL, Davies JM, Domino KB: Massive hemorrhage. A report from the Anesthesia Closed Claims Project. Anesthesiology 2014;121:450-458.
9.
Bohlmann MK, Rath W: Medical prevention and treatment of postpartum hemorrhage: a comparison of different guidelines. Arch Gynecol Obstet 2014;289:555-567.
10.
Schlembach D, Mortl MG, Girard T, Arzt W, Beinder E, Brezinka C, Chalubinski K, Fries D, Gogarten W, Hackeloer BJ, Helmer H, Henrich W, Hosli I, Husslein P, Kainer F, Lang U, Pfanner G, Rath W, Schleussner E, Steiner H, Surbek D, Zimmermann R: Management of postpartum hemorrhage (PPH): algorithm of the interdisciplinary D-A-CH consensus group PPH (Germany - Austria - Switzerland) (in German). Anaesthesist 2014;63:234-242.
11.
DeLee J: A case of fatal hemorrhagic diathesis, with premature detachment of the placenta. Am J Obstet Gynecol 1901;44:785-792.
12.
Shaylor R, Weiniger CF, Austin N, Tzabazis A, Shander A, Goodnough LT, Butwick AJ: National and international guidelines for patient blood management in obstetrics: a qualitative review. Anesth Analg 2017;124:216-232.
13.
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF, Association of scientific medical societies in Germany): AWMF Guidance Manual and Rules for Guideline Development. 2012. www.awmf.org/fileadmin/user_upload/Leitlinien/AWMF-Regelwerk/AWMF-Guidance_2013.pdf (last accessed August 30, 2017).
14.
Tuncalp O, Souza JP, Gulmezoglu M, World Health O: New WHO recommendations on prevention and treatment of postpartum hemorrhage. Int J Gynaecol Obstet 2013;123:254-256.
15.
American College of Obstetricians Gynecologists (ACOG): ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006:postpartum hemorrhage. Obstet Gynecol 2006;108:1039-1047.
16.
Neb H, Zacharowski K, Meybohm P: Strategies to reduce blood product utilization in obstetric practice. Curr Opin Anaesthesiol 2017;30:294-299.
17.
Abdul-Kadir R, McLintock C, Ducloy AS, El-Refaey H, England A, Federici AB, Grotegut CA, Halimeh S, Herman JH, Hofer S, James AH, Kouides PA, Paidas MJ, Peyvandi F, Winikoff R: Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion 2014;54:1756-1768.
18.
Kramer MS, Berg C, Abenhaim H, Dahhou M, Rouleau J, Mehrabadi A, Joseph KS: Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. Am J Obstet Gynecol 2013;209:449 e441-447.
19.
Antony KM, Dildy GA, 3rd: Postpartum hemorrhage: the role of the Maternal-fetal medicine specialist in enhancing quality and patient safety. Semin Perinatol 2013;37:246-256.
20.
Main EK, Goffman D, Scavone BM, Low LK, Bingham D, Fontaine PL, Gorlin JB, Lagrew DC, Levy BS; National Parntership for Maternal Safety, Council for Patient Safety in Women's Health Care: National Partnership for Maternal Safety: consensus bundle on obstetric hemorrhage. Anesth Analg 2015;121:142-148.
21.
Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De RE, Filipescu DC, Fries D, Gorlinger K, Haas T, Imberger G, Jacob M, Lance M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelso AJ, Wouters P, Wyffels P: Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013;30:270-382.
22.
Rajan PV, Wing DA: Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment. Clin Obstet Gynecol 2010;53:165-181.
23.
Siboni SM, Spreafico M, Calo L, Maino A, Santagostino E, Federici AB, Peyvandi F: Gynaecological and obstetrical problems in women with different bleeding disorders. Haemophilia 2009;15:1291-1299.
24.
Lee CA, Chi C, Pavord SR, Bolton-Maggs PH, Pollard D, Hinchcliffe-Wood A, Kadir RA: The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia 2006;12:301-336.
25.
Baskett TF: A flux of the reds: evolution of active management of the third stage of labour. J R Soc Med 2000;93:489-493.
26.
Carvalho JC, Balki M, Kingdom J, Windrim R: Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol 2004;104:1005-1010.
27.
George RB, McKeen D, Chaplin AC, McLeod L: Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery. Can J Anaesth 2010;57:578-582.
28.
Rossi AC, Lee RH, Chmait RH: Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol 2010;115:637-644.
29.
Balki M, Tsen L: Oxytocin protocols for cesarean delivery. Int Anesthesiol Clin 2014;52:48-66.
30.
Lavoie A, McCarthy RJ, Wong CA: The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study. Anesth Analg 2015;121:159-164.
31.
Dyer RA, Butwick AJ, Carvalho B: Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist. Curr Opin Anaesthesiol 2011;24:255-261.
32.
Kenyon S, Tokumasu H, Dowswell T, Pledge D, Mori R: High-dose versus low-dose oxytocin for augmentation of delayed labour. Cochrane Database Syst Rev 2013;7:CD007201.
33.
Stephens LC, Bruessel T: Systematic review of oxytocin dosing at caesarean section. Anaesth Intensive Care 2012;40:247-252.
34.
Zwolińska E, Zwoliński J: The use of carbetocin in prevention and treatment of PPH. 13th World Congress in Fetal Medicine. https://fetalmedicine.org/abstracts/ 2014/abstracts/149.pdf (last accessed August 30, 2017).
35.
Gizzo S, Patrelli TS, Gangi SD, Carrozzini M, Saccardi C, Zambon A, Bertocco A, Fagherazzi S, D'Antona D, Nardelli GB: Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reprod Sci 2013;20:1011-1019.
36.
Lampati L, Colantonio LB, Calderini E: Cardiac arrest during sulprostone administration - a case report. Acta Anaesthesiol Scand 2013;57:395-397.
37.
Henrich W, Surbek D, Kainer F, Grottke O, Hopp H, Kiesewetter H, Koscielny J, Maul H, Schlembach D, von Tempelhoff GF, Rath W: Diagnosis and treatment of peripartum bleeding. J Perinat Med 2008;36:467-478.
38.
Ahonen J, Stefanovic V, Lassila R: Management of post-partum haemorrhage. Acta Anaesthesiol Scand 2010;54:1164-1178.
39.
Green L, Knight M, Seeney FM, Hopkinson C, Collins PW, Collis RE, Simpson N, Weeks A, Stanworth SS: The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional study. BJOG 2016;123:2164-2170.
40.
Weeks AD, Mallaiah S: Beyond MBRRACE: new developments to stem the tide of postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2016;199:66-68.
41.
Ahonen J: The role of recombinant activated factor VII in obstetric hemorrhage. Curr Opin Anaesthesiol 2012;25:309-314.
42.
de Lange NM, Lance MD, de GR, Beckers EA, Henskens YM, Scheepers HC: Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv 2012;67:426-435.
43.
James AH, McLintock C, Lockhart E: Postpartum hemorrhage: when uterotonics and sutures fail. Am J Hematol 2012;87(suppl 1):S16-S22.
44.
Thachil J, Toh CH: Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 2009;23:167-176.
45.
Hofmann-Kiefer KF, Knabl J, Martinoff N, Schiessl B, Conzen P, Rehm M, Becker BF, Chappell D: Increased serum concentrations of circulating glycocalyx components in HELLP syndrome compared to healthy pregnancy: an observational study. Reprod Sci 2013;20:318-325.
46.
Djelmis J, Ivanisevic M, Kurjak A, Mayer D: Hemostatic problems before, during and after delivery. J Perinat Med 2001;29:241-246.
47.
Solomon C, Collis RE, Collins PW: Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 2012;109:851-863.
48.
McLintock C, James AH: Obstetric hemorrhage. J Thromb Haemost 2011;9:1441-1451.
49.
Collins P, Abdul-Kadir R, Thachil J; for the Subcommittees on Women's Health Issues in Thrombosis and Haemostasis and on Disseminated Intravascular Coagulation: Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH. J Thromb Haemost 2016;14:205-210.
50.
Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, Mandelbrot L, Tillouche N, Fontaine S, Le GF, Depret-Mosser S, Vallet B, Group ES, Susen S: High-dose tranexamic acid reduces blood loss in post-partum haemorrhage. Crit Care 2011;15:R117.
51.
Ducloy-Bouthors AS, Duhamel A, Kipnis E, Tournoys A, Prado-Dupont A, Elkalioubie A, Jeanpierre E, Debize G, Peynaud-Debayle E, DeProst D, Huissoud C, Rauch A, Susen S: Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial. Br J Anaesth 2016;116:641-648.
52.
Shakur H, Elbourne D, Gulmezoglu M, Alfirevic Z, Ronsmans C, Allen E, Roberts I: The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010;11:40.
53.
Moloney W, Phillips L, Pritchard J, Ratnoff O, Reid D, Schneider C: Management of the obstetrical patient with hemorrhage due to an acute or subacute defibrination syndrome. Blood 1959;14:1354-1367.
54.
Collis RE, Collins PW: Haemostatic management of obstetric haemorrhage. Anaesthesia 2015;70(suppl 1): 78-86, e27-78.
55.
Niepraschk-von Dollen K, Bamberg C, Henkelmann A, Mickley L, Kaufner L, Henrich W, Pauly F: Predelivery maternal fibrinogen as a predictor of blood loss after vaginal delivery. Arch Gynecol Obstet 2016;294:745-751.
56.
Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A: Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015;70:166-175.
57.
Wikkelso AJ, Edwards HM, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C, Ekelund K, Hanke G, Secher EL, Sharif HF, Pedersen LM, Troelstrup A, Lauenborg J, Mitchell AU, Fuhrmann L, Svare J, Madsen MG, Bodker B, Moller AM, group F-Pt: Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth 2015;114:623-633.
58.
Trigg DE, Stergiotou I, Peitsidis P, Kadir RA: A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. Haemophilia 2012;18:25-33.
59.
Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bodker B, Magnusdottir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G: Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. Obstet Gynecol 2007;110:1270-1278.
60.
Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry: Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg 2009;109:1908-1915.
61.
Zatta A, McQuilten Z, Kandane-Rathnayake R, Isbister J, Dunkley S, McNeil J, Cameron P, Phillips L: The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII. Blood Transfus 2015;13:86-99.
62.
Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC: Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. J Thromb Haemost 2015;13:520-529.
63.
Peitsidis P, Kadir RA: Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother 2011;12:503-516.
64.
Lier H, Krep H, Schroeder S, Stuber F: Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008;65:951-960.
65.
Royal College of Obstetricians and Gynaecologists (RCOG): Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a. www.rcog.org.uk/globalassets/documents/guidelines/gtg-37a.pdf (last accessed August 30, 2017).
66.
Schochl H, Voelckel W, Maegele M, Kirchmair L, Schlimp CJ: Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients. Crit Care 2014:R147.
67.
Karlsson O, Jeppsson A, Hellgren M: Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? Int J Obstet Anesth 2014;23:10-17.
68.
James AH, Konkle BA, Bauer KA: Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency. Int J Women Health 2013;5:233-241.
69.
Karlsson O, Sporrong T, Hillarp A, Jeppsson A, Hellgren M: Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy. Anesth Analg 2012;115:890-898.
70.
Rossen J, Okland I, Nilsen OB, Eggebo TM: Is there an increase of postpartum hemorrhage, and is severe hemorrhage associated with more frequent use of obstetric interventions? Acta Obstet Gynecol Scand 2010;89:1248-1255.
71.
Fuller AJ, Bucklin BA: Blood product replacement for postpartum hemorrhage. Clin Obstet Gynecol 2010;53:196-208.
72.
National Institute for Health and Clinical Excellence (NICE): Major trauma: Assessment and Initial Management (NG39),.2016. www.nice.org.uk/guidance/ng39 (last accessed August 30, 2017).
73.
Bonnet MP, Deneux-Tharaux C, Bouvier-Colle MH: Critical care and transfusion management in maternal deaths from postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2011;158:183-188.
74.
Liumbruno GM, Meschini A, Liumbruno C, Rafanelli D: The introduction of intra-operative cell salvage in obstetric clinical practice: a review of the available evidence. Eur J Obstet Gynecol Reprod Biol 2011;159:19-25.
75.
Waldron S: Hypotension associated with leucocyte depletion filters following cell salvage in obstetrics. Anaesthesia 2011;66:133-134.
76.
Campbell JP, Mackenzie MJ, Yentis SM, Sooranna SR, Johnson MR: An evaluation of the ability of leucocyte depletion filters to remove components of amniotic fluid. Anaesthesia 2012;67:1152-1157.
77.
Goucher H, Wong CA, Patel SK, Toledo P: Cell Salvage in Obstetrics. Anesth Analg 2015;121:465-468.
78.
Sreelakshmi TR, Eldridge J: Acute hypotension associated with leucocyte depletion filters during cell salvaged blood transfusion. Anaesthesia 2010;65:742-744.
79.
Kessack LK, Hawkins N: Severe hypotension related to cell salvaged blood transfusion in obstetrics. Anaesthesia 2010;65:745-748.
80.
James AH, Grotegut C, Ahmadzia H, Peterson-Layne C, Lockhart E: Management of coagulopathy in postpartum hemorrhage. Semin Thromb Hemost 2016;42:724-731.
81.
Pacheco LD, Saade GR, Gei AF, Hankins GD: Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol 2011;205:526-532.
82.
Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP: Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009;66:41-48.
83.
Ekelund K, Hanke G, Stensballe J, Wikkelsoe A, Albrechtsen CK, Afshari A: Hemostatic resuscitation in postpartum hemorrhage - a supplement to surgery. Acta Obstet Gynecol Scand 2015;94:680-692.
84.
Toulon P, Ozier Y, Ankri A, Fleron MH, Leroux G, Samama CM: Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009;101:394-401.
85.
Panteleev MA, Hemker HC: Global/integral assays in hemostasis diagnostics: promises, successes, problems and prospects. Thromb J 2015;13:5.
86.
de Lange NM, van Rheenen-Flach LE, Lance MD, Mooyman L, Woiski M, van Pampus EC, Porath M, Bolte AC, Smits L, Henskens YM, Scheepers HC: Peri-partum reference ranges for ROTEM(R) thromboelastometry. Br J Anaesth 2014;112:852-859.
87.
Collins PW, Lilley G, Bruynseels D, Laurent DB, Cannings-John R, Precious E, Hamlyn V, Sanders J, Alikhan R, Rayment R, Rees A, Kaye A, Hall JE, Paranjothy S, Weeks A, Collis RE: Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood 2014;124:1727-1736.
88.
Lier H, Hinkelbein J: Coagulation therapy in multiple trauma without point-of-care testing (in German). Unfallchirurg 2014;117:105-110.
89.
Lier H, Rath W: Aktuelle interdisziplinäre Handlungsempfehlungen bei schweren peri-(post-) partalen Blutungen (PPH). Geburtsh Frauenheilk 2011;17:577-588.
© 2017 S. Karger GmbH, Freiburg
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.